Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Plan
SEC Form 4
Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 1,328 shares of common stock at $6.57 per share on August 15, 2024, under a pre-arranged trading plan.
Summary
- On August 15, 2024, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc. (HCAT), sold 1,328 shares of the company's common stock.
- The sale was executed at a price of $6.57 per share.
- This transaction was conducted under a pre-arranged trading plan adopted on May 23, 2023, in accordance with Rule 10b5-1.
- Following the transaction, Llewelyn directly owns 118,536 shares of Health Catalyst common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock sale under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Insider transactions are routinely monitored and reported to the SEC. Sales under 10b5-1 plans are common and allow insiders to sell shares without being accused of acting on non-public information.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.
Key Dates
| Date | Description |
|---|---|
| May 23, 2023 | Date the reporting person adopted the written trading plan in accordance with rule 10b5-1 |
| August 15, 2024 | Date of the transaction (stock sale) |
| August 16, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.